Submission Details
| 510(k) Number | K920212 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 16, 1992 |
| Decision Date | August 20, 1992 |
| Days to Decision | 217 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
K920212 is an FDA 510(k) clearance for the MYCOPLASMA PNEUMONIAE ANTIBODY EIA TEST SYSTEM, a Enzyme Linked Immunoabsorbent Assay, Mycoplasma Spp. (Class I — General Controls, product code LJZ), submitted by Shared Systems, Inc. (Martinez, US). The FDA issued a Cleared decision on August 20, 1992, 217 days after receiving the submission on January 16, 1992. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3375.
| 510(k) Number | K920212 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 16, 1992 |
| Decision Date | August 20, 1992 |
| Days to Decision | 217 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
| Product Code | LJZ — Enzyme Linked Immunoabsorbent Assay, Mycoplasma Spp. |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3375 |